EN HU

Póka Róbert

Póka Róbert

Publication list

Uploaded publications:
309
Publications in DEA:
301
OA:
115
Date range:
1987-2026
2026
1.
Kunkli, A., Rátonyi, D., Kozma, B., Farkas, B., Majoros, L., Póka, R., Sipos, A. G., Takács, P., Krasznai, Z. T., Kozma, B.: Cervicovaginal zinc and copper profiles across vaginitis phenotypes and hydrogel assignment: an exploratory pilot study.
BMC Women's Health. [Epub ahead of print], 2026.
Journal metrics:
Q1 Medicine (miscellaneous) (2025)
Q1 Obstetrics and Gynecology (2025)
Q1 Reproductive Medicine (2025)
2.
Lorusso, D., Gladieff, L., O'Malley, D. M., Kim, J. W., Garbaos, G., Fagotti, A., Gilbert, L., Mileshkin, L., Quesada, S., Hopp, E., Lee, Y. J., Oaknin, A., Scaranti, M., Kim, B. G., Clamp, A., Prillaman, C., Diakos, C., Bagaméri, A., Leiser, A. L., Salutari, V., Monk, B. J., Follana, P., McClung, E., Carbone, V., Slomovitz, B. M., Giudice, E., Cannizzaro, M. C., Gavoille, L., Devaux, A., Scollo, P., Scandurra, G., Cassani, C., Artioli, G., Van Gorp, T., Santaballa, A., Dreiling, L. K., Kesner-Hays, A., Tudor, I. C., Jubb, A. M., Colombo, N., Olawaiye, A. B., Medical Research Council Ethics Committee for Clinical Pharmacology: Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.
Lancet. 407 (10538), 1513-1524, 2026.
3.
Póka, R.: Új adatok a korai méhnyakrák műtéti kezelésének evolúciójához.
Orv. hetil. 167 (7), 251-256, 2026.
Journal metrics:
Q4 Medicine (miscellaneous) (2025)
2025
4.
Hojny, J., Dvorak, J., Vránková, R., Bártủ, M., Hájková, N., Krkavcová, E., Flídrová, M., Struzinská, I., Nĕmejcová, K., Bouda, J., Michalová, K., Cibula, D., Poncová, R., Ryś, J., Książek, M., Jedryka, M. A., Poprawski, T., Berjon, A., Zapardiel, I., Laco, J., Ndukwe, M., Klat, J., Židlík, V., Krasznai, Z. T., Póka, R., Zikán, M., Špůrková, Z., Bizon, M., Sawicki, W., Volodko, N., Yezhova, I., Ciccarone, F., Zinicola, G., Bobinski, M., Ostrowska-Lesko, M., Franin, I., Kekic, M., Piatnytska, T., Varchak, I., Pilka, R., Marek, R., Hausnerová, J., Koblízková, M., Havelka, P., Kalist, V., Stukan, M., Grabowska, K., Kolnikova, G., Krkoska, M., Halaska, M., Drozenová, J., Stolnicu, S., Căpîlna, M. E., Sharashenidze, A., Gudadze, M., Matej, R., Dundr, P.: Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights.
Lab. Invest. 105 (9), 1-14, (article identifier: 104198), 2025.
Journal metrics:
Q2 Cell Biology
Q1 Molecular Biology
D1 Pathology and Forensic Medicine
5.
Flídrová, M., Dundr, P., Vránková, R., Nĕmejcová, K., Cibula, D., Poncová, R., Michalová, K., Bouda, J., Laco, J., Ndukwe, M., Ryś, J., Książek, M., Berjon, A., Zapardiel, I., Franin, I., Njavro, A., Hausnerová, J., Bretová, P., Židlík, V., Klat, J., Krasznai, Z. T., Póka, R., Volodko, N., Yezhova, I., Pilka, R., Marek, R., Kolnikova, G., Krkoska, M., Halaska, M., Drozenová, J., Dolinská, D., Kalist, V., Bobinski, M., Ostrowska-Lesko, M., Bizon, M., Sawicki, W., Stukan, M., Grabowska, K., Jedryka, M. A., Poprawski, T., Stolnicu, S., Căpîlna, M. E., Špůrková, Z., Zikán, M., Ciccarone, F., Scambia, G., Sharashenidze, A., Gudadze, M., Piatnytska, T., Varchak, I., Kendall Bártů, M.: Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series.
Virchows Arch. 486 (6), 1289-1304, 2025.
Journal metrics:
Q2 Cell Biology
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Pathology and Forensic Medicine
6.
Borčinová, M., Köhler, C., Nĕmejcová, K., Zapardiel, I., Klat, J., Frühauf, F., Kalist, V., Szatkowski, W., Wydra, D., Kocian, R., Laky, R., Tóth, R., Misiek, M., Redecha, M., Martin, I., Kridelka, F., Burgetová, A., Santiago Garcia, F. J., Van Gorp, T., Szewczyk, G., Kipp, B., Póka, R., Coronado, P. J., Cadron, I., Luyckx, M., Fischerová, D., Fischbach, R., Cibula, D.: Preoperative tumour size assessment in patients with early-stage cervical cancer: final results of the SENTIX study.
Gynecol. Oncol. 196, 160-167, 2025.
Journal metrics:
D1 Obstetrics and Gynecology
Q1 Oncology
7.
Oza, A. M., Lisyanskaya, A., Fedenko, A., de Melo, A. C., Shparyk, Y., Rakhmatullina, I., Bondarenko, I. M., Colombo, N., Svintsitskiy, V., Biela, L., Nechaeva, M., Lorusso, D., Scambia, G., Cibula, D., Póka, R., Oaknin, A., Safra, T., Mackowiak-Matejczyk, B., Ma, L., Thomas, D., Lin, K., McLachlan, K., Goble, S., Kristeleit, R. S.: Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial.
Lancet Oncol. 26 (2), 249-264, 2025.
Journal metrics:
D1 Oncology
8.
Manzour, N., Chiva, L., Zanagnolo, V., Căpîlna, M. E., Bizzarri, N., Mom, C., Klasa, Ł., Malzoni, M., Arencibia Sanchez, O., Narducci, F., Raspagliesi, F., Póka, R., Golub, D., Tavares, M., Tsolakidis, D., Shamistan, A., Perrone, A. M., Pete, I., Aluloski, I., Bernardino, M., Vujic, G., Jedryka, M. A., Maenpaa, M. M., Ponce, J., Povolotskaya, N., Rivas, F. R., Feron, J. G., Van Gorp, T., Alonso-Espías, M., Fruscio, R., Vorgias, G., Garcia, J., Herrero, S., Kavallaris, A., Luyckx, M., Yezhova, I., Mitrovic, M., Ferrero, A., Saaron, R., Sukhin, V., SUCCOR study group: SUCCOR 10 Years: a Decade's Perspective on Radical Hysterectomy Outcomes in Cervical Cancer.
Int. J. Gynecol. Cancer. 35 (5), (article identifier: 101690), 2025.
Journal metrics:
D1 Obstetrics and Gynecology
Q1 Oncology
9.
Dundr, P., Hojny, J., Dvorak, J., Hájková, N., Vránková, R., Krkavcová, E., Berjon, A., Bizon, M., Bobinski, M., Bouda, J., Bui, Q. H., Căpîlna, M. E., Ciccarone, F., Flídrová, M., Fröbe, A., Grabowska, K., Halaska, M., Hausnerová, J., Jedryka, M. A., Laco, J., Kalist, V., Klat, J., Kolnikova, G., Książek, M., Marek, R., Matej, R., Michal, M., Michalová, K., Ndukwe, M., Nĕmejcová, K., Petróczy, D., Piatnytska, T., Póka, R., Poprawski, T., Ryś, J., Sawicki, W., Sharashenidze, A., Stolnicu, S., Struzinská, I., Špůrková, Z., Volodko, N., Zapardiel, I., Zikán, M., Židlík, V., Cibula, D., Poncová, R., Kendall Bártů, M.: The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas.
Lab. Invest. 105 (5), 1-14, (article identifier: 104092), 2025.
Journal metrics:
Q2 Cell Biology
Q1 Molecular Biology
D1 Pathology and Forensic Medicine
2024
10.
Pepin, J. T., Chon, H. S., Sundborg, M. J., Gold, M. A., Kim, B. G., Blank, S. V., Liu, J. H., McCollum, M., Mori, M., Moore, M. N., Diaz, J. R., Joseph de Padua, C. A., Martinez-Garcia, J., Papadimitriou, C., Gri an, K., Póka, R., Kowgier, M., Oscroft, E., Nieuwenhuysen, E. V., Westin, S. N.: Safety and tolerability of durvalumab + carboplatin/paclitaxel followed by durvalumab +/- olaparib in patients with newly diagnosed advanced or recurrent endometrial cancer (EC) in the DUO-E/GOG-3041/ENGOT-EN10 trial.
J. Clin. Oncol. 42 (16), 599, 2024.
11.
Vergote, I., González-Martín, A., Fujiwara, K., Kalbacher, E., Bagaméri, A., Ghamande, S., Lee, J. Y., Banerjee, S., Maluf, F. C., Lorusso, D., Yonemori, K., Van Nieuwenhuysen, E., Manso, L., Woelber, L., Westermann, A., Covens, A., Hasegawa, K., Kim, B. G., Raimondo, M., Bjurberg, M., Cruz, F. M., Angelergues, A., Cibula, D., Barraclough, L., Oaknin, A., Gennigens, C., Nicacio, L., Teng, M. S. L., Whalley, E., Soumaoro, I., Slomovitz, B. M., innovaTV 301/ENGOT-cx12/GOG-3057 Collaborators: Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
N. Engl. J. Med. 391 (1), 44-55, 2024.
2023
12.
Slama, J., Runnebaum, I. B., Scambia, G., Angeles, M. A., Bahrehmand, K., Kommoss, S., Fagotti, A., Narducci, F., Matylevich, O., Holly, J., Martinelli, F., Koual, M., Kopetskyi, V., El-Balat, A., Corrado, G., Căpîlna, M. E., Schröder, W., Novák, Z., Shushkevich, A., Fricová, L., Cibula, D., FERTIlity Sparing Surgery (FETISS) study: Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study.
Am. J. Obstet. Gynecol. 228 (4), 443, 2023.
13.
Bogani, G., Ray-Coquard, I., Concin, N., Ngoi, N. Y. L., Morice, P., Caruso, G., Enomoto, T., Takehara, K., Denys, H., Lorusso, D., Coleman, R., Vaughan, M. M., Takano, M., Provencher, D., Sagae, S., Wimberger, P., Póka, R., Segev, Y., Kim, S. I., Kim, J. W., Candido dos Reis, F. J., Ramirez, P. T., Mariani, A., Leitao, M. M., Makker, V., Abu-Rustum, N. R., Vergote, I., Zannoni, G. F., Tan, D. S. P., McCormack, M., Paolini, B., Bini, M., Raspagliesi, F., Benedetti Panici, P., Di Donato, V., Muzii, L., Colombo, N., Pignata, S., Scambia, G., Monk, B. J.: Endometrial carcinosarcoma.
Int. J. Gynecol. Cancer. 33 (2), 147-174, 2023.
Journal metrics:
Q1 Obstetrics and Gynecology
Q2 Oncology
14.
Árokszállási, A., Molnár, S., Damjanovich, P. G., Lukács, J., Kovács, I., Deliné Molnár, S., Póka, R., Hernádi, Z., Lampé, R., Krasznai, Z. T.: Immunellenőrzőpont-gátlók a cervix- és endometriumcarcinoma kezelésének gyakorlatában - összefoglaló a Debreceni Egyetem Nőgyógyászati Onkológiai Tanszék betegeinek terápiás eredményeiről.
Magy Onkol. 67 (Suppl_1), 9-10, 2023.
2022
15.
Póka, R.: Ágystruktúra a hazai szülészeti ellátásában: javaslatok a stratégiai fejlesztéshez.
Magy Noorv Lapja. 85, 28-32, 2022.
16.
Póka, R.: Ágystruktúra a hazai szülészeti ellátásban: javaslatok a stratégiai fejlesztéshez.
Magy Noorv Lapja. 85, 61-65, 2022.
17.
Borčinová, M., Ragosch, V., Jarkovský, J., Bajsová, S., Pilka, R., Glickman, A., Garrido-Mallach, S., Raspagliesi, F., Szatkowski, W., Pakiz, M., Snyman, L. C., Kocian, R., Tamussino, K., Kalist, V., Michal, M., Segovia, M. G., Póka, R., Kipp, B., Szewczyk, G., Wydra, D., Tóth, R., Vinnytska, A., Fischerová, D., Siegler, K., Cibula, D.: Challenges in lower limb lymphoedema assessment based on limb volume change: lessons learnt from the SENTIX prospective multicentre study.
Gynecol. Oncol. 164 (1), 76-84, 2022.
Journal metrics:
D1 Obstetrics and Gynecology
Q1 Oncology
18.
Bogani, G., Ray-Coquard, I., Concin, N., Ngoi, N. Y. L., Morice, P., Enomoto, T., Takehara, K., Denys, H., Lorusso, D., Coleman, R., Vaughan, M. M., Takano, M., Provencher, D., Sagae, S., Wimberger, P., Póka, R., Segev, Y., Kim, S. I., Kim, J. W., Candido dos Reis, F. J., Mariani, A., Leitao, M. M., Makker, V., Rustum, N. A., Vergote, I., Zannoni, G. F., Tan, D. S. P., McCormack, M., Bini, M., Lopez, S., Raspagliesi, F., Panici, P. B., Di Donato, V., Muzii, L., Colombo, N., Scambia, G., Pignata, S., Monk, B. J.: Clear cell carcinoma of the endometrium.
Gynecol. Oncol. 164 (3), 658-666, 2022.
Journal metrics:
D1 Obstetrics and Gynecology
Q1 Oncology
19.
Csécsei, K., Csehely, S., Póka, R., Zádor, Z., Németh, I., Ringelhan, B., Deliné Molnár, S., Jakab, A.: Haemangioma a méhnyakban: 4 eset ismertetése és irodalmi áttekintés.
Orv. hetil. 163 (5), 187-194, 2022.
Journal metrics:
Q4 Medicine (miscellaneous)
20.
Ledermann, J. A., Zurawski, B., Raspagliesi, F., De Giorgi, U., Arranz Arija, J., Romeo Marin, M., Lisyanskaya, A., Póka, R., Markowska, J., Cebotaru, C., Casado Herraez, A., Colombo, N., Kutarska, E., Hall, M., Jacobs, A., Ahrens-Fath, I., Baumeister, H., Zurlo, A., Sehouli, J.: Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study.
ESMO Open. 7 (1), 1-8, (article identifier: 100311), 2022.
Journal metrics:
Q1 Cancer Research
Q1 Oncology
21.
Kristeleit, R. S., Lisyanskaya, A., Fedenko, A., Dvorkin, M., de Melo, A. C., Shparyk, Y., Rakhmatullina, I., Bondarenko, I. M., Colombo, N., Svintsitskiy, V., Biela, L., Nechaeva, M., Lorusso, D., Scambia, G., Cibula, D., Póka, R., Oaknin, A., Safra, T., Mackowiak-Matejczyk, B., Ma, L., Thomas, D., Lin, K., McLachlan, K., Goble, S., Oza, A. M.: Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.
Lancet Oncol. 23, 465-478, 2022.
Journal metrics:
D1 Oncology
22.
Chacon, E., Manzour, N., Zanagnolo, V., Querleu, D., Núñez-Córdoba, J. M., Martin-Calvo, N., Căpîlna, M. E., Fagotti, A., Kucukmetin, A., Mom, C., Chakalova, G., Shamistan, A., Gil Moreno, A., Malzoni, M., Narducci, F., Arencibia Sanchez, O., Raspagliesi, F., Toptas, T., Cibula, D., Kaidarova, D., Meydanli, M. M., Tavares, M., Golub, D., Perrone, A. M., Póka, R., Tsolakidis, D., Vujic, G., Jedryka, M. A., Zusterzeel, P., Beltman, J. J., Goffin, F., Haidopoulos, D., Haller, H., Jach, R., Yezhova, I., Berlev, I., Bernardino, M., Bharathan, R., Lanner, M., Maenpaa, M. M., Sukhin, V., Feron, J. G., Fruscio, R., Kukk, K., Ponce, J., Minguez, J. A., Vázquez-Vicente, D., Castellanos, T., Boria, F., Alcazar, J. L., Chiva, L., SUCCOR study group: SUCCOR cone study: conization before radical hysterectomy.
Int. J. Gynecol. Cancer. 32 (2), 117-124, 2022.
Journal metrics:
D1 Obstetrics and Gynecology
Q2 Oncology
23.
Boria, F., Chiva, L., Chacon, E., Zanagnolo, V., Fagotti, A., Kucukmetin, A., Mom, C., Chakalova, G., Shamistan, A., Malzoni, M., Narducci, F., Arencibia Sanchez, O., Raspagliesi, F., Toptas, T., Cibula, D., Kaidarova, D., Meydanli, M. M., Tavares, M., Golub, D., Perrone, A. M., Póka, R., Zusterzeel, P., Aluloski, I., Goffin, F., Haidopoulos, D., Haller, H., Jach, R., Yezhova, I., Bernardino, M., Bharathan, R., Maenpaa, M. M., Sukhin, V., Feron, J. G., Fruscio, R., Kukk, K., Ponce, J., Demirkiran, F., Vorgias, G., Povolotskaya, N., Coronado Martin, P. J., Marina, T., Zapardiel, I., Bizzarri, N., Gorostidi, M., Gutierrez, M., Manzour, N., Berasaluce, A., SUCCOR study group: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer.
Int. J. Gynecol. Cancer. 32 (10), 1236-1243, 2022.
Journal metrics:
D1 Obstetrics and Gynecology
Q2 Oncology
24.
Manzour, N., Chiva, L., Chacon, E., Martin-Calvo, N., Boria, F., Minguez, J. A., Alcazar, J. L., SUCCOR study group: SUCCOR Risk: design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer.
Ann. Surg. Oncol. 29 (8), 4819-4829, 2022.
2021
25.
Póka, R., Török, O.: Analysis of nationwide reflection of rising cesarean section rate in neonatal outcomes of Hungary.
J. Obstet. Gynaecol. Res. 47 (2), 785-791, 2021.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Obstetrics and Gynecology
DEENK University of Debrecen
© 2012 University of Debrecen